Modulation of growth factor functionality through immobilization in starPEG-heparin networks

• Main Author: Zieris, Andrea
• Other Authors: Technische Universität Dresden, Fakultät Mathematik und Naturwissenschaften
• Format: Doctoral Thesis
• Language: English
• Published: Saechsische Landesbibliothek- Staats- und Universitaetsbibliothek Dresden 2012
• Subjects: Hydrogel; Wachstumsfaktor; Immobilisierung; Freisetzung; Angiogenese; Growth Factor; Immobilization; Release; Angiogenesis; ddc:570; rvk:WD 5970
• Online Access: http://nbn-resolving.de/urn:nbn:de:bsz:14-qucosa-89158; http://nbn-resolving.de/urn:nbn:de:bsz:14-qucosa-89158; http://www.qucosa.de/fileadmin/data/qucosa/documents/8915/Dissertation_Andrea_Zieris.pdf

Effective vascularization is crucial for almost any therapeutic tissue engineering concept. In this context, therapeutic angiogenesis attempts to enforce the natural process of blood vessel formation by provision of bioactive effectors. Along these lines, the aim of this work was to evaluate the potential of a modular hydrogel composed of the synthetic star-shaped poly(ethylene glycol) (starPEG) and the naturally occurring biopolymer heparin for the defined and orchestrated delivery of two major angiogenic growth factors, fibroblast growth factor-2 (FGF-2) and vascular endothelial growth factor (VEGF). While starPEG determines the structural properties of the gel materials, effective administration of both cytokines is based on their natural affinity to heparin, the highly charged polysaccharidic building block capable of reversibly binding various growth factors upon geometrically matching electrostatic interactions. Varying the molar ratio of starPEG to heparin upon network formation, different hydrogel types with distinct mechanical characteristics but constant heparin content could be produced. As heparin represents the basis for the growth factor interaction with the scaffolds, the matrices were found to bind and release FGF-2 or VEGF independently of the particular network stiffness and structural properties of the different gel types. Moreover, the material could be utilized for a modular delivery of growth factor combinations over a broad range of concentrations. To evaluate the general suitability for pro-angiogenic stimulation, the provision of FGF-2 and VEGF from starPEG-heparin hydrogels differing in their mechanical characteristics and biofunctionalization with adhesive peptides was studied using human endothelial cells, the cell type that forms the inner layer of any blood vessel. Results showed that the presence of the adhesion ligand was an essential requirement to mediate cell attachment and subsequent growth on the scaffolds. Apart from that, hydrogels with an intermediate stiffness showed beneficial effects on endothelial cell proliferation/survival while in parallel also the differentiation into elongated, pro-tubular structures could be promoted. While the delivery of FGF-2 was able to enhance cell growth, VEGF mainly initiated endothelial cell shape elongation. However, with a parallel administration of both growth factors, their beneficial effects could be combined to obtain high numbers of endothelial cells undergoing differentiation. Furthermore, besides the possibility of growing endothelial cells on top of the biofunctionalized hydrogels, the release of growth factors by starPEG-heparin matrices could be applied as a stimulus to attract the cells to migrate into the direction of the scaffolds. While FGF-2 and VEGF supported cell motility to a similar extent, their combined action was found to exert the strongest effect on endothelial cell migration. Based on the results of these in vitro experiments, matrices most effectively stimulating pro-angiogenic cellular responses were selected for in vivo studies applying the functionalized materials to the chorioallantoic membrane (CAM) of fertilized chicken eggs, an assay commonly used to evaluate the vascularization potential of biomaterials. In this assay, the delivery of FGF-2 and/or VEGF by starPEG-heparin hydrogels induced a substantial angiogenic response within the CAM system, while the combination of both growth factors tends to increase vascularization most effectively. In order to adjust the starPEG-heparin hydrogel system to the complex requirements of therapeutic angiogenesis, further options to specifically modulate the FGF-2 or VEGF release were explored. With the incorporation of enzymatically cleavable peptide linkers, not only the possibility for a cellular remodeling of the gel matrix could be permitted, but also the growth factor release was substantially enhanced upon network degradation. Moreover, with the gradual removal of FGF-2 and VEGF interaction sites from heparin upon selective desulfation, the binding of both growth factors to hydrogels composed out of starPEG and desulfated heparin was significantly reduced depending on the remaining sulfate content. Irrespective of the lower immobilized amounts of FGF-2 or VEGF, higher absolute quantities of both growth factors could be released and retained in the medium due to their decreased affinity to heparin, thereby enhancing the delivery efficiency of the scaffolds. Going beyond common concepts for triggered cytokine release, hydrogel-bound FGF-2 or VEGF could be effectively displaced from their heparin binding sites by an application of the competitive, highly-heparin affine molecule chitosan. As chitosan could be introduced at different time points, not only the amounts of delivered growth factor were enhanced, but also the FGF-2 or VEGF release kinetics could be specifically modulated. Taken together, starPEG-heparin hydrogels with independently adaptable physical and biomolecular composition were demonstrated to provide time-resolved multi-factor delivery of pro-angiogenic growth factors resulting in valuable new options for therapeutic angiogenesis.